anti-vaccine
Mumps cases in England rocket four-fold to highest point in a decade
February 14, 2020Medical Communications, Research and Development MMR vaccine, Vaccine, anti-vaccine, pharma
The incidence of mumps in the England has reached its highest level in 10 years, prompting warnings from health officials …
Over half of all anti-vaccine ads on Facebook stem from just two advertisers
November 15, 2019Medical Communications, Research and Development Facebook, anti-vaccine, pharma
A new study has revealed that the largest share of anti-vaccine advertisements on Facebook originate from just two organisations, both …
Twitter launches new initiative to direct users towards credible information on vaccines
May 17, 2019Medical Communications Twitter, anti-vaccine, health, pharma, social media, vaccines
Twitter will now present users with a pinned tweet directing them towards reliable information on vaccines, according to a blog …
Japanese court orders public health campaigner to pay ¥3.3 million to anti-vaccine researcher
March 27, 2019Medical Communications, Research and Development HPV, Japan, anti vaxx, anti-vaccine, public health, vaccines
Dr Riko Muranaka, a researcher and journalist who has campaigned against misinformation surrounding vaccines, has been ordered to pay ¥3.3 …
Anti-vaxxers: Vaccines in the age of populism
November 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing anti vaccine, anti-vaccine, history, medicine, populism, vaccines
Mistrust of the establishment has fuelled anti-vaccine sentiment in recent years, and adherence has waned as a result. Louis Goss …
Parents should ignore anti-vaccine “social media fake news”, according to England’s medical chief
November 1, 2018Medical Communications England, MMR, Vaccine, anti-vaccine, fake news
England’s Chief Medical Officer Dame Sally Davies has said that the MMR vaccine is “a safe vaccination” as she encouraged …
Latest content
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
